UNSPSC 51263169: Metoprolol tartrate

This classification denotes a beta-adrenergic blocking agent with the molecular formula 2C15H25NO3.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5S57Y3A5L, chemically known as 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)- but more generally known as metoprolol tartrate, which bears US NIH Compound Identifier 4171. European Medicines Agency schedules Metoprolol tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03275MIG.

UNSPSC 51263169 Metoprolol tartrate is a Commodity code that nominally designates a specific pharmaceutical product, but the recent state and local opportunities tagged under it show little alignment with that narrow scope. The two posted solicitations — one from Seminole County, Florida seeking naloxone and drug deactivation systems, and one from Texas Health and Human Services Commission exploring direct-to-manufacturer prescription programs — do not target metoprolol tartrate or single-drug procurement. The code appears to reflect either broad pharmaceutical purchasing activity or a tagging mismatch in the issuing bodies' procurement systems. State and local governments soliciting under this code span county health departments and state health agencies, though the recent record is too sparse to characterize a clear issuing-body pattern or to establish that metoprolol tartrate itself is a material procurement target.

Seminole County, Florida posted an IFB on June 30, 2026 (response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building and a two-year initial term plus one-year renewal option. Texas HHS issued a Request for Information on April 3, 2026 to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. Geographic activity is limited to Florida and Texas in the available record. The code shows insufficient recent activity specifically tied to metoprolol tartrate procurement to support a reliable assessment of market demand or issuing-body concentration under this Commodity code.